These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24945341)

  • 21. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate.
    Edwards KR; Sackellares JC; Vuong A; Hammer AE; Barrett PS
    Epilepsy Behav; 2001 Feb; 2(1):28-36. PubMed ID: 12609179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
    Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine for bipolar disorder: translating research into clinical practice.
    Fung J; Mok H; Yatham LN
    Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder.
    Chang CC; Shiah IS; Chang HA; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):147-50. PubMed ID: 16225978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of patients with bipolar II disorder.
    Yatham LN
    J Clin Psychiatry; 2005; 66 Suppl 1():13-7. PubMed ID: 15693747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Muck-Seler D; Sagud M; Mustapic M; Nedic G; Babic A; Mihaljevic Peles A; Jakovljevic M; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1195-8. PubMed ID: 18423830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
    Sajatovic M; Ramsay E; Nanry K; Thompson T
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):945-50. PubMed ID: 17326238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained remission with lamotrigine augmentation or monotherapy in female resistant depressives with mixed cyclothymic-dysthymic temperament.
    Manning JS; Haykal RF; Connor PD; Cunningham PD; Jackson WC; Long S
    J Affect Disord; 2005 Feb; 84(2-3):259-66. PubMed ID: 15708424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three cases of reversible agranulocytosis after treatment with lamotrigine.
    Ahn YM; Kim K; Kim YS
    Psychiatry Investig; 2008 Jun; 5(2):121-3. PubMed ID: 20046355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine-Associated Progressive Dysphasia and Cognitive Dysfunction.
    Brown JC; Broadway JL
    OBM Neurobiol; 2021 Oct; 5(2):. PubMed ID: 37091351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sinus Bradycardia in an Adolescent Taking Lamotrigine.
    Davis G; Ward K; Mohiuddin S
    Case Rep Psychiatry; 2022; 2022():3353684. PubMed ID: 35601676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The resolution of eczema during treatment with lamotrigine: a case report.
    Bajwa WK; Stevens CA
    Prim Care Companion CNS Disord; 2012; 14(3):. PubMed ID: 23106020
    [No Abstract]   [Full Text] [Related]  

  • 37. Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation.
    Chen QW; Li QR; Cao MW; Yan JH; Zhang XZ
    Adv Sci (Weinh); 2022 Jun; 9(17):e2200986. PubMed ID: 35434937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jaundice and hepatic enzyme induction during lamotrigine therapy in a bipolar II patient.
    Selek S; Savas HA; Savas E; Herken H; Tutkun H; Gergerlioglu HS
    Int J Psychiatry Clin Pract; 2005; 9(1):65-7. PubMed ID: 24945341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine: a depression mood stabiliser.
    Herman E
    Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.